LU88738I2 - Hormone Folliculo-Stimulante humaine recombinante (follitropine alpha) et ses dérivés pharmaceutiquement acceptables GONAL-F - Google Patents
Hormone Folliculo-Stimulante humaine recombinante (follitropine alpha) et ses dérivés pharmaceutiquement acceptables GONAL-FInfo
- Publication number
- LU88738I2 LU88738I2 LU88738C LU88738C LU88738I2 LU 88738 I2 LU88738 I2 LU 88738I2 LU 88738 C LU88738 C LU 88738C LU 88738 C LU88738 C LU 88738C LU 88738 I2 LU88738 I2 LU 88738I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- folliculo
- gonal
- pharmaceutically acceptable
- recombinant human
- stimulating hormone
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title abstract 2
- 239000005556 hormone Substances 0.000 title abstract 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title 1
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/696,647 US4923805A (en) | 1983-11-02 | 1985-01-30 | Fsh |
Publications (1)
Publication Number | Publication Date |
---|---|
LU88738I2 true LU88738I2 (fr) | 1996-08-23 |
Family
ID=24797972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU88738C LU88738I2 (fr) | 1985-01-30 | 1986-01-30 | Hormone Folliculo-Stimulante humaine recombinante (follitropine alpha) et ses dérivés pharmaceutiquement acceptables GONAL-F |
Country Status (12)
Country | Link |
---|---|
US (1) | US4923805A (fr) |
EP (2) | EP0521586B1 (fr) |
JP (5) | JPH0724584B2 (fr) |
KR (1) | KR910002692B1 (fr) |
AT (1) | ATE87317T1 (fr) |
DE (3) | DE211894T1 (fr) |
DK (2) | DK171601B1 (fr) |
HK (1) | HK143295A (fr) |
LU (1) | LU88738I2 (fr) |
MX (1) | MX9203681A (fr) |
NL (1) | NL960004I2 (fr) |
WO (1) | WO1986004589A1 (fr) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639639A (en) * | 1983-11-02 | 1997-06-17 | Genzyme Corporation | Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof |
US4840896A (en) * | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
US5156957A (en) * | 1983-11-02 | 1992-10-20 | Genzyme Corporation | Follicle stimulating hormone |
US6455282B1 (en) * | 1983-11-02 | 2002-09-24 | Genzyme Corporation | Cells, vectors and methods for producing biologically active TSH |
US4921808A (en) * | 1986-06-25 | 1990-05-01 | The Albany Medical College Of Union University | Method for determining follicle stimulating hormone |
US6150328A (en) * | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
CA2045131A1 (fr) * | 1989-01-11 | 1990-07-12 | Frederic E. Wondisford | Thyrotrophine synthetique biologiquement active et gene clone servant a la produire |
US5338835A (en) * | 1989-02-21 | 1994-08-16 | Washington University | CTP-extended form of FSH |
EP0461200B1 (fr) * | 1989-02-21 | 1997-01-22 | Washington University | Formes modifiees d'hormones de reproduction |
US6225449B1 (en) * | 1991-10-04 | 2001-05-01 | Washington University | Hormone analogs with multiple CTP extensions |
US5087615A (en) * | 1989-03-17 | 1992-02-11 | Applied Research Systems Ars Holding N.V. | Novel method of ovulation induction in humans |
EP0404458A3 (fr) * | 1989-06-19 | 1992-03-04 | Bunge (Australia) Proprietary Limited | Hormone ovine stimulant le follicule |
US5240832A (en) * | 1989-06-20 | 1993-08-31 | Genzyme Corporation | Heteropolymeric protein production methods |
EP0612348B1 (fr) * | 1991-11-04 | 2003-04-23 | Genetics Institute, LLC | Proteines heterodimeres morphogenetiques d'os de recombinaison, compositions et procedes d'utilisation |
US20080139474A1 (en) * | 1991-11-04 | 2008-06-12 | David Israel | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
US6291206B1 (en) * | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
US6737515B2 (en) | 1993-11-19 | 2004-05-18 | Washington University | Follicle stimulating hormone-glycosylation analogs |
ES2255059T3 (es) * | 1993-12-07 | 2006-06-16 | Genetics Institute, Llc | Bmp-12, bmp-13 y composiciones suyas inductoras de tendon. |
US6238890B1 (en) * | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
US6727224B1 (en) * | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
US7112341B1 (en) | 1999-04-13 | 2006-09-26 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility |
EP2286847A1 (fr) | 1999-10-15 | 2011-02-23 | Genetics Institute, LLC | Formulations à base d'acide hyaluronique aux fins de l'administration de proteines osteogenes |
US6824822B2 (en) * | 2001-08-31 | 2004-11-30 | Alkermes Controlled Therapeutics Inc. Ii | Residual solvent extraction method and microparticles produced thereby |
US20030082233A1 (en) * | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
IL140110A0 (en) * | 2000-12-05 | 2002-02-10 | Applied Research Systems | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
ES2305246T3 (es) * | 2001-06-01 | 2008-11-01 | Wyeth | Composiciones para la administracion sistemica de secuencias que codifican proteinas oseas morfogeneticas. |
TWI267378B (en) * | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
CN105131104B (zh) | 2001-10-10 | 2018-11-16 | 诺和诺德公司 | 肽的重构和糖缀合 |
NZ535008A (en) * | 2002-02-08 | 2005-09-30 | Alkermes Inc | Polymer-based compositions for sustained release |
CA2486113A1 (fr) * | 2002-05-17 | 2003-12-04 | Wyeth | Vehicules injectables solides contenant de l'acide hyaluronique pour l'administration de proteines osteogenes |
EP1610803B8 (fr) * | 2003-03-04 | 2011-09-14 | AspenBio Pharma, Inc. | LH pour utilisation pour maintenir une ou plusieurs grossesses en induisant la formation du corps jaune secondaire. |
EP2338333B1 (fr) | 2003-04-09 | 2017-09-06 | ratiopharm GmbH | Méthode de glycopegylation et proteines/peptides produits au moyen de ces méthodes |
US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
UA88879C2 (en) * | 2003-09-02 | 2009-12-10 | Эплайд Рисерч Системз Эрс Холдинг Н.В. | Fsh glycosylation mutant |
EP2374471A1 (fr) * | 2003-09-12 | 2011-10-12 | Wyeth LLC | Pâtes de phosphate de calcium injectables et durcissables pour la délivrance de protéines ostéogènes |
KR100533794B1 (ko) * | 2003-10-02 | 2005-12-07 | 주식회사 프로젠 | 인간 난포자극 호르몬을 대량으로 생산하는 방법 |
KR100587535B1 (ko) * | 2004-02-04 | 2006-06-08 | 충남대학교산학협력단 | 재조합 hFSH 유전자 및 이를 내장하는 발현용 벡터 |
US7456254B2 (en) * | 2004-04-15 | 2008-11-25 | Alkermes, Inc. | Polymer-based sustained release device |
ATE531374T1 (de) * | 2004-04-15 | 2011-11-15 | Alkermes Inc | Vorrichtung auf polymerbasis mit verzögerter freisetzung |
US20060110423A1 (en) * | 2004-04-15 | 2006-05-25 | Wright Steven G | Polymer-based sustained release device |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
EP2266561A3 (fr) | 2005-09-07 | 2011-05-18 | Merck Serono S.A. | Inhibiteurs de l'IKK pour le traitement de l'endométriose |
US7682356B2 (en) | 2006-08-09 | 2010-03-23 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies for use therein |
JP5351884B2 (ja) | 2007-04-23 | 2013-11-27 | インターシア セラピューティクス,インコーポレイティド | インスリン分泌促進性ペプチドの懸濁製剤及び使用 |
UA103598C2 (uk) | 2007-06-28 | 2013-11-11 | Биодженерикс Аг | Клон клітин, що продукують fsh |
KR101573773B1 (ko) | 2008-02-08 | 2015-12-02 | 바이오제너릭스 게엠베하 | Fsh의 액체 포뮬레이션 |
CA2726861C (fr) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques |
JP2009273427A (ja) | 2008-05-16 | 2009-11-26 | Jcr Pharmaceuticals Co Ltd | 組換え体ヒトfshの製造方法 |
JP5845170B2 (ja) | 2009-04-01 | 2016-01-20 | ラティオファーム ゲーエムベーハー | 組換えfshを精製する方法 |
HUE035862T2 (en) | 2009-09-28 | 2018-05-28 | Intarcia Therapeutics Inc | Rapid development and / or completion of substantially steady-state drug delivery |
EP2325194A1 (fr) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Processus de purification de glycoprotéines |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
CN103509121B (zh) | 2012-11-22 | 2015-01-28 | 苏州康宁杰瑞生物科技有限公司 | 一种fsh融合蛋白及其制备方法和用途 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
ES2968262T3 (es) | 2015-06-03 | 2024-05-08 | I2O Therapeutics Inc | Sistemas de colocación de implantes |
WO2017200943A1 (fr) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Polypeptides sélectifs du récepteur du glucagon et méthodes pour les employer |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468464A (en) * | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
JPS586475B2 (ja) | 1980-08-23 | 1983-02-04 | 株式会社 林原生物化学研究所 | ヒト絨毛性性腺刺激ホルモンの製造方法 |
JPS585671B2 (ja) * | 1980-08-27 | 1983-02-01 | 株式会社 林原生物化学研究所 | ヒト卵胞刺激ホルモンの製造方法 |
US4419446A (en) * | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4840896A (en) * | 1983-11-02 | 1989-06-20 | Integrated Genetics, Inc. | Heteropolymeric protein |
WO1985001959A1 (fr) * | 1983-11-02 | 1985-05-09 | Integrated Genetics, Inc. | Production d'hormones heterodimeriques de la fertilite chez l'homme |
FR2565599B1 (fr) * | 1984-06-08 | 1989-08-25 | Integrated Genetics Inc | Sequence d'adnc codant pour la beta fsh porcine, vecteur la comprenant, beta fsh produite et son utilisation |
WO1986000923A1 (fr) * | 1984-07-31 | 1986-02-13 | Integrated Genetics, Inc. | Vecteurs de clonage de levure |
-
1985
- 1985-01-30 US US06/696,647 patent/US4923805A/en not_active Expired - Lifetime
-
1986
- 1986-01-30 EP EP92202323A patent/EP0521586B1/fr not_active Expired - Lifetime
- 1986-01-30 DE DE198686901246T patent/DE211894T1/de active Pending
- 1986-01-30 AT AT86901246T patent/ATE87317T1/de active
- 1986-01-30 LU LU88738C patent/LU88738I2/fr unknown
- 1986-01-30 DE DE19675006C patent/DE19675006I2/de active Active
- 1986-01-30 MX MX9203681A patent/MX9203681A/es unknown
- 1986-01-30 JP JP61501080A patent/JPH0724584B2/ja not_active Expired - Lifetime
- 1986-01-30 EP EP86901246A patent/EP0211894B1/fr not_active Expired - Lifetime
- 1986-01-30 DE DE8686901246T patent/DE3688109T2/de not_active Expired - Lifetime
- 1986-01-30 WO PCT/US1986/000223 patent/WO1986004589A1/fr active IP Right Grant
- 1986-09-29 DK DK463586A patent/DK171601B1/da not_active IP Right Cessation
- 1986-09-30 KR KR1019860700673A patent/KR910002692B1/ko not_active IP Right Cessation
-
1993
- 1993-06-30 JP JP5162603A patent/JP2559196B2/ja not_active Expired - Lifetime
-
1995
- 1995-01-30 JP JP7012474A patent/JPH0829106B2/ja not_active Expired - Lifetime
- 1995-01-30 JP JP7012468A patent/JP2683563B2/ja not_active Expired - Lifetime
- 1995-09-07 HK HK143295A patent/HK143295A/xx not_active IP Right Cessation
- 1995-12-20 DK DK199501446A patent/DK172625B1/da not_active IP Right Cessation
-
1996
- 1996-03-15 NL NL960004C patent/NL960004I2/nl unknown
- 1996-09-25 JP JP8252989A patent/JP2757982B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MX9203681A (es) | 1992-09-01 |
DE211894T1 (de) | 1991-06-13 |
WO1986004589A1 (fr) | 1986-08-14 |
DK463586D0 (da) | 1986-09-29 |
JP2757982B2 (ja) | 1998-05-25 |
EP0521586B1 (fr) | 1999-06-23 |
EP0211894A4 (fr) | 1987-10-12 |
JPH07255492A (ja) | 1995-10-09 |
NL960004I2 (nl) | 1997-04-01 |
DK171601B1 (da) | 1997-02-17 |
US4923805A (en) | 1990-05-08 |
JPS63500212A (ja) | 1988-01-28 |
DK144695A (da) | 1995-12-20 |
JPH07241194A (ja) | 1995-09-19 |
DE3688109T2 (de) | 1993-07-15 |
HK143295A (en) | 1995-09-15 |
JPH09173064A (ja) | 1997-07-08 |
EP0521586A1 (fr) | 1993-01-07 |
KR870700074A (ko) | 1987-02-28 |
ATE87317T1 (de) | 1993-04-15 |
KR910002692B1 (ko) | 1991-05-03 |
JPH0724584B2 (ja) | 1995-03-22 |
DK463586A (da) | 1986-09-29 |
NL960004I1 (nl) | 1996-09-02 |
JPH0829106B2 (ja) | 1996-03-27 |
JP2559196B2 (ja) | 1996-12-04 |
DE3688109D1 (en) | 1993-04-29 |
DK172625B1 (da) | 1999-03-15 |
JPH06253884A (ja) | 1994-09-13 |
EP0211894A1 (fr) | 1987-03-04 |
DE19675006I2 (de) | 2008-06-12 |
JP2683563B2 (ja) | 1997-12-03 |
EP0211894B1 (fr) | 1993-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU88738I2 (fr) | Hormone Folliculo-Stimulante humaine recombinante (follitropine alpha) et ses dérivés pharmaceutiquement acceptables GONAL-F | |
UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
LU90806I2 (fr) | Ovidrelle-choriogonadotropine alfa et ses d-riv-s pharmaceutiquement acceptables | |
NO880863D0 (no) | Humant erytropoietingen: hoey ekspresjon i stabilt transfekterte pattedyrceller. | |
GT198277746A (es) | Interteron inmune humano | |
ZA886471B (en) | Conjugates of cytokines with imunologulins | |
DK163930C (da) | Biologisk aktivt peptid og peptidfragment deraf med natriuretisk, diuretisk og vasodilataterende aktivitet og terapeutisk middel indeholdende et saadant peptid eller peptidfragment | |
DK0504177T3 (da) | IL-11, et pattedyrcytokin | |
ES2009215A6 (es) | Procedimiento de preparar un derivado de interleucina-1beta. | |
HU9300624D0 (en) | Medical preparatives for treating hard tumours containing il-4 as active substance and method for produicng them | |
ATE194917T1 (de) | Flüssige beta-interferon formulierungen | |
EP0129582A4 (fr) | Peptides et proteines biologiquement actifs pour administration orale. | |
ATE109206T1 (de) | O-glycosylierter igf-1. | |
EP0180737A3 (en) | Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases | |
FI950883A (fi) | BAPP-C100-reseptorin kloonaus ja ilmentäminen | |
JO1238B1 (en) | Pharmacy formulations include human insulin, human peptide-C and the human insulin component | |
JO1209B1 (en) | Pharmacy formulations that include human insulin and the human insulin component. | |
NO941982L (no) | Fremstilling av proteiner ved anvendelse av 7B2 protein | |
ATE98217T1 (de) | Terpen-amino-alkohole und deren medizinische verwendung. |